Stockreport

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology [Yahoo! Finance]

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF Itolizumab demonstrated a favorable safety and tolerability profile LA JOLLA, Calif., November 13, 2023 BUSINESS WIRE Equillium , Inc. (Nasdaq: EQ), a clinical-stage [Read more]